The Effect of Bases and Formulation on the Release of Indomethacin from Suppositories

The in vitro release characteristics of indomethacin from different suppository formulations were investigated using a dialysis method. Suppositories containing 100 mg of indomethacin were prepared by the fusion method in a variety of Witepsol and Novata bases with different hydroxyl values. The rate of release of indomethacin was found to be unexpectedly higher from oily bases with low hydroxyl values.

Furthermore, the effect of surface active agents and some excipients commonly used in suppository formulations on the release properties of indomethacin was determined. Colloidal silicon dioxide, sodium lauryl sulphate and cetyl alcohol had a slight effect, on the release of indomethacin, whereas dioctyl sodium sulphosuccinate significantly increased the amount of indomethacin released. White beeswax and Tween-80, however, resulted in a marked decrease in the release of indomethacin.

The in vitro release of indomethacin from five commercially available preparations was also determined using the same method. Suppositories formulated in PEG bases gave better release properties than those in oily bases.